首页> 外文期刊>Journal of Bone Oncology >Telangiectatic osteosarcoma: Outcome analyses and a diagnostic model for differentiation from aneurysmal bone cyst
【24h】

Telangiectatic osteosarcoma: Outcome analyses and a diagnostic model for differentiation from aneurysmal bone cyst

机译:毛细血管扩张性骨肉瘤:与动脉瘤性骨囊肿相鉴别的结果分析和诊断模型

获取原文
           

摘要

Background and purpose Telangiectatic osteosarcoma (TOS), a rare variant of osteosarcoma, may be easily misdiagnosed as aneurysmal bone cyst (ABC). The aims of this study were to investigate the diagnostic and prognostic factors of TOS by reviewing our experience with TOS and to develop a diagnostic model that may distinguish TOS from ABC. Materials and methods We identified 51 cases of TOS treated at the First Affiliated Hospital of Sun Yat-Sen University from March 2001 to January 2016 and reviewed their records, imaging information and pathological studies. A diagnostic model was developed to differentiate TOS and ABC by Bayes discriminant analysis and was evaluated. The log-rank test was used to analyze the prognostic factors of TOS and to compare the outcome differences between TOS and other high-grade osteosarcoma subtypes. Results The multi-disciplinary diagnostic method employed that combined clinical, imaging, and pathological studies enhanced the diagnostic accuracy. Age 18 years or younger and pathologic fracture were more common among the TOS patients than among the ABC patients (P = .004 and .005, respectively). The average white blood cell (WBC), platelet, lactate dehydrogenase (LDH), and alkaline phosphatase (ALP) values of the TOS patients were higher than those of the ABC patients ( P = .002, .003, .007, and .007, respectively). Our diagnostic model, including the aforementioned factors, accurately predicted 62% and 78% of the TOS patients in the training and validation sets, respectively. The 5-year estimates of event-free survival and overall survival of the TOS patients were 52.5 ± 9.4% and 54.9 ± 8.8%, respectively, which were similar to those of patients with other osteosarcoma subtypes ( P = .950 and .615, respectively). Tumor volume and the LDH level were predictive prognostic factors ( P = .040 and .044) but not the presence of pathologic fracture or misdiagnosis ( P = .424 and .632, all respectively). Conclusions The multi-disciplinary diagnostic method and diagnostic model based on predictive factors, i.e. , age, the presence of pathologic fracture, and platelet, LDH, ALP and WBC levels, aided the differentiation of TOS and ABC. Smaller tumors and normal LDH levels were associated with better outcomes.
机译:背景与目的毛细血管扩张性骨肉瘤(TOS)是骨肉瘤的一种罕见变体,很容易被误诊为动脉瘤性骨囊肿(ABC)。这项研究的目的是通过回顾我们在TOS方面的经验来调查TOS的诊断和预后因素,并开发出可以将TOS与ABC区分开来的诊断模型。材料和方法我们确定了2001年3月至2016年1月在中山大学附属第一医院接受治疗的TOS的51例病例,并对其记录,影像学信息和病理学研究进行了回顾。建立了诊断模型以通过贝叶斯判别分析来区分TOS和ABC并进行了评估。使用log-rank检验分析TOS的预后因素,并比较TOS与其他高级骨肉瘤亚型之间的预后差异。结果结合临床,影像学和病理学研究采用的多学科诊断方法提高了诊断准确性。与ABC患者相比,TOS患者中18岁以下的年轻人和病理性骨折更为常见(分别为P = 0.004和.005)。 TOS患者的平均白细胞(WBC),血小板,乳酸脱氢酶(LDH)和碱性磷酸酶(ALP)值均高于ABC患者(P = .002,.003,.007和。 007)。我们的诊断模型(包括上述因素)分别在训练和验证集中准确预测了62%和78%的TOS患者。 TOS患者无事件生存期和总生存期的5年估算分别为52.5±9.4%和54.9±8.8%,与其他骨肉瘤亚型患者的相似(P = .950和.615,分别)。肿瘤体积和LDH水平是预测的预后因素(P = .040和.044),但不是病理性骨折或误诊(P分别为.424和.632)。结论基于年龄,病理性骨折以及血小板,LDH,ALP和WBC水平等预测因素的多学科诊断方法和诊断模型有助于TOS和ABC的鉴别。较小的肿瘤和正常的LDH水平与较好的预后相关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号